Clinical Evaluation of Moment Tumor Hip Replacement Products Within the Scope of Substantial Clinical Trials
The aim is to ensure that the patients are functionally adequately and painlessly mobilized with the proximal femoral tumor resection prosthesis used, to increase the survival of patients who underwent wide resection, and to determine the complications of the treatment applied and the clinical performance of the Moment Tumor Hip Replacement Products used.
• Adults of both sexes aged 18-79 years
• For patients with bone loss, fractures, pseudarthrosis due to primary-secondary metastases in the hip femoral region, patients belonging to one or more of the following groups
• Patients with or with bone resections due to infection
• Patients with unsuccessful femoral component applications
• Patients in need of long-term stabilization of major bone defects caused by fractures with major and irreversible bone loss, periprosthetic fractures, traumatic non-tumor conditions affecting the trunks of the long bones, and comminuted fractures
• Patients with severe pain and loss of function in the proximal femoral region
• Patients with incompetence of the upper end of the femur or femoral neck fracture in hip replacement revisions.
• Have sufficient mental and physical capacity to sign the informed consent form for the procedure